Metabolic dysfunction-associated steatotic liver disease (MASLD) can be a possible predictive factor of incident CKD: NAGALA cohort study - Yuriko Ono; Kimiko Sakai; Takuro Okamura; Hiroshi Okada; Akihiro Obora; Takao Kojima; Masahide Hamaguchi; Michiaki Fukui (PLoS ONE, 2025)